
  
    
      
        Background_NNP
        The_DT tetraspanins_NNS are_VBP a_DT family_NN of_IN cell-surface_JJ proteins_NNS
        with_IN four_CD transmembrane_NN domains_NNS ,_, two_CD extracellular_NN loops_NNS ,_,
        and_CC conserved_JJ cysteine_NN residues_NNS at_IN key_JJ positions_NNS in_IN the_DT
        second_JJ extracellular_NN loop_NN [_NN 1_CD ]_NN ._. They_PRP facilitate_VBP a_DT wide_JJ
        array_NN of_IN functions_NNS ,_, including_VBG cell_NN activation_NN ,_,
        differentiation_NN ,_, adhesion_NN ,_, morphological_JJ changes_NNS ,_, and_CC
        motility_NN ,_, which_WDT may_MD all_DT relate_VB to_TO the_DT promiscuous_JJ
        associations_NNS of_IN these_DT molecules_NNS with_IN integrins_NNS and_CC other_JJ
        signaling_VBG proteins_NNS within_IN the_DT cell_NN membrane_NN and_CC the_DT
        cytoskeleton_NN ._.
        CD_NNP 81_CD ,_, a_DT defining_VBG member_NN of_IN the_DT tetraspanin_NN superfamily_RB ,_,
        is_VBZ widely_RB expressed_VBN on_IN human_JJ hematopoietic_JJ and_CC other_JJ cells_NNS
        [_NN 2_CD ]_NN ._. It_PRP associates_NNS on_IN B_NNP cells_NNS with_IN a_DT signaling_VBG complex_JJ
        that_WDT includes_VBZ CD_NNP 19_CD and_CC CD_NNP 21_CD [_NN 3_CD ]_NN ,_, as_RB well_RB as_IN associating_VBG
        with_IN MHC_NNP class_NN II_NNP molecules_NNS [_NN 4_CD ]_NN and_CC other_JJ tetraspanins_NNS [_NN
        5_CD 6_CD ]_NN ._. On_IN T_NN cells_NNS ,_, CD_NNP 81_CD interacts_NNS with_IN CD_NNP 4_CD ,_, CD_NNP 8_CD ,_, CD_NNP 82_CD ,_, and_CC
        selected_VBD integrins_NNS [_NN 7_CD 8_CD 9_CD 10_CD ]_NN ._.
        An_DT anti-_NN CD_NNP 81_CD antibody_NN was_VBD first_RB isolated_VBN for_IN its_PRP$ ability_NN
        to_TO induce_VB cell_NN death_NN in_IN B_NNP cell_NN lines_NNS [_NN 11_CD ]_NN ._. This_DT is_VBZ
        likely_JJ dependent_JJ upon_IN CD_NNP 81_CD 's_POS association_NN with_IN MHC_NNP class_NN II_NNP
        molecules_NNS ,_, which_WDT can_MD transmit_VB death-inducing_JJ signals_NNS in_IN B_NNP
        cells_NNS [_NN 12_CD ]_NN ._. CD_NNP 81_CD cross-linking_JJ can_MD also_RB induce_VB adhesion_NN
        in_IN B_NNP and_CC T_NN cells_NNS ,_, apparently_RB by_IN multiple_JJ pathways_NNS [_NN 10_CD 13_CD
        14_CD ]_NN ._. Triggering_VBG of_IN the_DT CD_NNP 19_CD -_: CD_NNP 21_CD -_: CD_NNP 81_CD complex_JJ on_IN murine_NN B_NNP
        cells_NNS has_VBZ been_VBN shown_VBN to_TO lower_VB the_DT threshold_NN for_IN B_NNP cell_NN
        activation_NN via_IN the_DT immunoglobulin_NN receptor_NN [_NN 15_CD ]_NN ._.
        On_IN murine_NN T_NN cells_NNS and_CC thymocytes_NNS ,_, CD_NNP 81_CD costimulates_NNS T_NN
        cell_NN receptor-mediated_JJ activation_NN ,_, through_IN a_DT pathway_NN
        independent_JJ of_IN CD_NNP 28_CD [_NN 16_CD ]_NN ._. On_IN human_JJ T_NN cells_NNS ,_, CD_NNP 81_CD
        costimulation_NN results_NNS in_IN increased_VBN IL-_NNP 2_CD production_NN and_CC
        LFA-_NNP 1_CD -_: mediated_JJ T-B_NNP cell_NN adhesion_NN [_NN 17_CD ]_NN ._. Murine_NNP CD_NNP 81_CD also_RB
        appears_VBZ to_TO play_VB a_DT role_NN in_IN thymocyte_NN maturation_NN as_IN shown_VBN in_IN
        fetal_JJ thymic_JJ organ_NN cultures_NNS [_NN 18_CD ]_NN ._.
        Finally_RB ,_, CD_NNP 81_CD signalling_VBG has_VBZ been_VBN shown_VBN to_TO have_VB an_DT
        effect_NN on_IN the_DT Th_NNP 1_CD /_NN Th_NNP 2_CD balance_NN of_IN immune_JJ responses_NNS ._. In_IN cell_NN
        cultures_NNS of_IN CD_NNP 4_CD T_NN cells_NNS and_CC B_NNP cells_NNS from_IN allergic_JJ
        individuals_NNS ,_, addition_NN of_IN anti-_NN CD_NNP 81_CD antibody_NN enhances_VBZ IL-_NNP 4_CD
        production_NN from_IN the_DT T_NN cells_NNS [_NN 19_CD ]_NN ._. In_IN mice_NNS ,_, either_CC
        complete_JJ lack_NN of_IN CD_NNP 81_CD ,_, or_CC lack_NN of_IN CD_NNP 81_CD on_IN B_NNP cells_NNS ,_, leads_VBZ to_TO
        impaired_VBN humoral_NN and_CC Th_NNP 2_CD immune_JJ responses_NNS [_NN 20_CD 21_CD ]_NN ._.
        Allergen-induced_NNP airway_NN hyperresponsiveness_NNS is_VBZ also_RB
        decreased_VBN in_IN CD_NNP 81_CD nullmice_NN [_NN 22_CD ]_NN ._. Finally_RB ,_, lack_NN of_IN CD_NNP 81_CD
        on_IN murine_NN T_NN cells_NNS diminishes_VBZ IL-_NNP 4_CD production_NN ,_, with_IN reduced_VBN
        expression_NN of_IN ICOS_NNP ,_, GATA-_NNP 3_CD ,_, STAT_NNP 6_CD and_CC phosphorylated_JJ STAT_NNP 6_CD
        [_NN 23_CD ]_NN ._.
        In_IN this_DT report_NN ,_, an_DT attempt_NN is_VBZ made_VBN to_TO reconcile_VB the_DT
        findings_NNS of_IN general_JJ T_NN cell_NN costimulation_NN versus_CC specific_JJ
        Th_NNP 2_CD biasing_VBG by_IN CD_NNP 81_CD in_IN human_JJ T_NN cells_NNS ._. Short-term_NNP CD_NNP 81_CD
        cross-linking_JJ on_IN normal_JJ human_JJ T_NN cells_NNS is_VBZ shown_VBN to_TO
        co-stimulate_JJ T_NN cell_NN activation_NN (_( via_IN antigen_NN or_CC
        superantigen_NN )_) ,_, extending_VBG previous_JJ findings_NNS in_IN mouse_NN
        splenocytes_NNS [_NN 16_CD ]_NN and_CC human_JJ PBMC_NNP [_NN 17_CD ]_NN ._. The_DT effect_NN
        appears_VBZ to_TO be_VB a_DT direct_JJ consequence_NN of_IN CD_NNP 81_CD triggering_VBG on_IN T_NN
        cells_NNS ._. Of_IN interest_NN ,_, production_NN of_IN both_DT Th_NNP 1_CD and_CC Th_NNP 2_CD
        cytokines_NNS is_VBZ augmented_JJ by_IN CD_NNP 81_CD costimulation_NN ._. However_RB ,_,
        during_IN longer-term_JJ stimulation_NN of_IN T_NN cells_NNS ,_, the_DT presence_NN of_IN
        CD_NNP 81_CD costimulation_NN leads_VBZ to_TO a_DT disproportionate_JJ increase_NN in_IN
        IL-_NNP 4_CD -_: producing_VBG cells_NNS ._. This_DT is_VBZ due_JJ to_TO increased_VBN induction_NN of_IN
        proliferation_NN ._. Thus_RB ,_, CD_NNP 81_CD signalling_VBG provides_VBZ short-term_JJ
        costimulation_NN of_IN cells_NNS producing_VBG Th_NNP 1_CD or_CC Th_NNP 2_CD cytokines_NNS ,_, but_CC
        results_NNS in_IN a_DT disproportionate_JJ increase_NN in_IN Th_NNP 2_CD
        cytokine-producing_JJ cells_NNS during_IN long-term_JJ activation_NN ._.
      
      
        Results_NNS
        
          CD_NNP 81_CD cross-linking_JJ costimulates_NNS CD_NNP 69_CD expression_NN and_CC
          IL-_NNP 2_CD induction_NN
          Two_CD early_JJ events_NNS in_IN T_NN cell_NN activation_NN are_VBP the_DT
          induction_NN of_IN CD_NNP 69_CD expression_NN and_CC the_DT stimulation_NN of_IN IL-_NNP 2_CD
          production_NN by_IN the_DT T_NN cells_NNS ._. To_TO determine_VB whether_IN
          costimulation_NN through_IN human_JJ CD_NNP 81_CD affected_VBD these_DT early_JJ
          activation_NN events_NNS ,_, peripheral_JJ blood_NN cells_NNS from_IN normal_JJ CMV_NNP
          seropositive_JJ donors_NNS were_VBD incubated_JJ for_IN 6_CD h_NN with_IN a_DT
          superantigen_NN ,_, SEB_NNP ,_, or_CC the_DT viral_JJ antigen_NN ,_, CMV_NNP ,_, in_IN the_DT
          presence_NN or_CC absence_NN of_IN an_DT agonistic_JJ anti-_NN CD_NNP 81_CD mAb_NN ,_, 5_CD A_DT 6_CD ._.
          As_IN seen_VBN in_IN Figure_NN 1_CD ,_, over_IN a_DT range_NN of_IN antigen_NN or_CC
          superantigen_NN concentrations_NNS ,_, the_DT addition_NN of_IN 5_CD A_DT 6_CD
          increased_VBD the_DT number_NN of_IN CD_NNP 69_CD +_NN cells_NNS as_RB well_RB as_IN the_DT number_NN
          of_IN IL-_NNP 2_CD -_: producing_VBG cells_NNS ,_, measured_VBN by_IN intracellular_NN
          staining_VBG ._. The_DT effect_NN of_IN anti-_NN CD_NNP 81_CD mAb_NN was_VBD often_RB greater_JJR
          than_IN that_DT of_IN the_DT classical_JJ costimulatory_NN antibody_NN ,_, CD_NNP 28_CD ._.
          The_DT effect_NN of_IN anti-_NN CD_NNP 81_CD was_VBD also_RB greater_JJR for_IN CD_NNP 4_CD +_NN T_NN cells_NNS
          (_( A_DT ,_, B_NNP ,_, E_NNP ,_, F_NN )_) compared_VBN to_TO CD_NNP 4_CD -_: T_NN cells_NNS (_( C_NNP ,_, D_NNP ,_, G_NNP ,_, H_NNP )_) ._. It_PRP
          also_RB appeared_VBD to_TO be_VB more_RBR dramatic_JJ for_IN CD_NNP 69_CD (_( A_DT ,_, C_NNP ,_, E_NNP ,_, G_NNP )_) than_IN
          for_IN IL-_NNP 2_CD (_( B_NNP ,_, D_NNP ,_, F_NN ,_, H_NNP )_) ._. As_IN such_JJ ,_, essentially_RB no_DT effect_NN was_VBD
          observed_VBN on_IN CD_NNP 8_CD (_( CD_NNP 3_CD +_NN CD_NNP 4_CD -_: )_) T_NN cell_NN IL-_NNP 2_CD production_NN
          (_( panels_NNS D_NNP and_CC H_NNP )_) ._. Stimulation_NNP with_IN 5_CD A_DT 6_CD alone_RB ,_, in_IN the_DT
          absence_NN of_IN SEB_NNP or_CC CMV_NNP ,_, gave_VBD consistently_RB =_SYM 0_CD ._. 05_CD %_NN
          cytokine-positive_JJ T_NN cells_NNS in_IN such_JJ experiments_NNS (_( data_NNS not_RB
          shown_VBN )_) ._. These_DT results_NNS confirm_VBP and_CC extend_VB the_DT findings_NNS of_IN
          VanCompernolle_NNP et_CC al_NN ._. [_NN 17_CD ]_NN on_IN CD_NNP 81_CD costimulation_NN of_IN
          SEB-induced_NNP CD_NNP 69_CD expression_NN ._.
          Similar_JJ to_TO results_NNS obtained_VBN by_IN VanCompernolle_NNP et_CC al_NN ._. [_NN
          17_CD ]_NN ,_, CD_NNP 81_CD costimulation_NN was_VBD also_RB found_VBN to_TO increase_VB
          SEB-specific_NNP proliferation_NN ,_, as_IN measured_VBN by_IN BrdU_NNP
          incorporation_NN (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          Effect_NN on_IN Th_NNP 1_CD and_CC Th_NNP 2_CD cytokines_NNS
          Since_IN CD_NNP 81_CD signaling_VBG has_VBZ been_VBN implicated_VBN in_IN the_DT mouse_NN
          to_TO be_VB preferentially_RB important_JJ for_IN Th_NNP 2_CD -_: dominated_VBN
          responses_NNS [_NN 21_CD ]_NN ,_, it_PRP was_VBD examined_VBN whether_IN CD_NNP 81_CD
          costimulation_NN in_IN human_JJ T_NN cells_NNS preferentially_RB induced_VBN Th_NNP 2_CD
          cytokine_NN production_NN over_IN Th_NNP 1_CD cytokine_NN production_NN ._. To_TO
          examine_VB this_DT ,_, 6_CD h_NN stimulation_NN with_IN SEB_NNP or_CC CMV_NNP was_VBD carried_VBN
          out_IN in_IN peripheral_JJ blood_NN cells_NNS of_IN normal_JJ human_JJ CMV_NNP
          seropositive_JJ donors_NNS ,_, in_IN the_DT presence_NN or_CC absence_NN of_IN
          anti-_NN CD_NNP 81_CD mAb_NN 5_CD A_DT 6_CD ,_, followed_VBN by_IN intracellular_NN staining_VBG for_IN
          IL-_NNP 2_CD ,_, IFNγ_NNP ,_, or_CC IL-_NNP 4_CD ._. As_IN seen_VBN in_IN Figure_NN 2_CD ,_, addition_NN of_IN 5_CD A_DT 6_CD
          approximately_RB doubled_VBD the_DT number_NN of_IN cytokine-producing_JJ
          cells_NNS for_IN each_DT cytokine_NN at_IN these_DT doses_NNS of_IN SEB_NNP (_( 0_CD ._. 1_LS μg_NN /_NN ml_NN )_)
          or_CC CMV_NNP (_( 0_CD ._. 5_LS μg_NN /_NN ml_NN )_) ._. There_EX was_VBD no_DT preferential_JJ
          costimulation_NN of_IN cells_NNS producing_VBG IL-_NNP 4_CD versus_CC IFNγ_NNP or_CC
          IL-_NNP 2_CD ._.
        
        
          CD_NNP 81_CD exerts_NNS a_DT direct_JJ effect_NN on_IN human_JJ T_NN cells_NNS
          To_TO determine_VB whether_IN the_DT effects_NNS observed_VBD in_IN the_DT above_JJ
          experiments_NNS were_VBD due_JJ to_TO direct_VB stimulation_NN of_IN CD_NNP 81_CD on_IN T_NN
          cells_NNS ,_, or_CC whether_IN indirect_JJ effects_NNS of_IN ligation_NN of_IN CD_NNP 81_CD on_IN
          other_JJ cells_NNS were_VBD involved_VBN ,_, the_DT following_VBG experiment_NN was_VBD
          carried_VBN out_RP ._. PBMC_NNP from_IN a_DT normal_JJ human_JJ donor_NN were_VBD depleted_VBN
          of_IN non-_NN T_NN cells_NNS by_IN magnetic_JJ bead_NN separation_NN ,_, then_RB T_NN cells_NNS
          and_CC non-_NN T_NN cells_NNS were_VBD independently_RB incubated_JJ with_IN 5_CD A_DT 6_CD
          anti-_NN CD_NNP 81_CD mAb_NN ,_, washed_VBN ,_, and_CC re-combined_JJ in_IN the_DT presence_NN of_IN
          SEB_NNP ._. As_IN seen_VBN in_IN Figure_NN 3_CD ,_, only_RB when_WRB the_DT T_NN cell_NN fraction_NN
          was_VBD incubated_JJ with_IN 5_CD A_DT 6_CD was_VBD costimulation_NN of_IN CD_NNP 69_CD
          expression_NN and_CC cytokine_NN production_NN observed_VBD ._. Thus_RB ,_, direct_JJ
          ligation_NN of_IN CD_NNP 81_CD on_IN T_NN cells_NNS was_VBD sufficient_JJ to_TO induce_VB
          costimulation_NN of_IN T_NN cell_NN activation_NN ._.
        
        
          Effect_NN of_IN CD_NNP 81_CD ligation_NN on_IN long-term_JJ T_NN cell_NN
          activation_NN
          Another_DT possible_JJ way_NN that_IN CD_NNP 81_CD could_MD affect_VB T_NN cell_NN
          cytokine_NN production_NN is_VBZ by_IN directing_VBG T_NN cells_NNS towards_IN Th_NNP 2_CD
          cytokine_NN production_NN during_IN long-term_JJ stimulation_NN ._. Other_JJ
          investigators_NNS have_VBP shown_VBN (_( in_IN mouse_NN systems_NNS )_) that_DT
          commitment_NN to_TO Th_NNP 1_CD or_CC Th_NNP 2_CD cytokine_NN production_NN by_IN naïve_NN T_NN
          cells_NNS requires_VBZ prior_RB cell_NN proliferation_NN [_NN 24_CD ]_NN ;_: and_CC
          reversal_NN of_IN Th_NNP 1_CD or_CC Th_NNP 2_CD -_: committed_VBN cells_NNS requires_VBZ at_IN least_JJS
          several_JJ days_NNS of_IN proliferation_NN [_NN 25_CD ]_NN ._. When_WRB normal_JJ human_JJ
          PBMC_NNP were_VBD stimulated_VBN for_IN 7_CD days_NNS with_IN SEB_NNP ,_, the_DT presence_NN of_IN
          5_CD A_DT 6_CD anti-_NN CD_NNP 81_CD mAb_NN resulted_VBD in_IN a_DT modest_JJ increase_NN in_IN
          IL-_NNP 4_CD -_: producing_VBG T_NN cells_NNS ,_, when_WRB those_DT cells_NNS were_VBD
          restimulated_JJ with_IN PMA_NNP and_CC ionomycin_NN (_( Figure_NN 4_CD A_DT )_) ._. No_DT
          significant_JJ change_NN in_IN IL-_NNP 2_CD -_: or_CC IFNγ-producing_NNP T_NN cells_NNS was_VBD
          seen_VBN ._. Similar_JJ results_NNS were_VBD seen_VBN when_WRB PBMC_NNP were_VBD stimulated_VBN
          with_IN plate-bound_JJ anti-_NN CD_NNP 3_CD mAb_NN ,_, rather_RB than_IN SEB_NNP ,_, for_IN 7_CD
          days_NNS in_IN the_DT presence_NN of_IN 5_CD A_DT 6_CD anti-_NN CD_NNP 81_CD mAb_NN (_( Figure_NN 4_CD B_NNP )_) ._.
          These_DT results_NNS were_VBD more_RBR dramatic_JJ when_WRB CD_NNP 45_CD RO_NNP +_NN cells_NNS were_VBD
          first_RB isolated_VBN ,_, by_IN magnetic_JJ bead_NN separation_NN ,_, and_CC then_RB
          subjected_VBN to_TO 7_CD d_SYM stimulation_NN by_IN anti-_NN CD_NNP 3_CD ,_, in_IN the_DT presence_NN
          or_CC absence_NN of_IN 5_CD A_DT 6_CD anti-_NN CD_NNP 81_CD mAb_NN ._. As_IN seen_VBN in_IN Figure_NN 4_CD C_NNP ,_,
          the_DT percentage_NN of_IN CD_NNP 4_CD +_NN T_NN cells_NNS producing_VBG IL-_NNP 4_CD upon_IN
          PMA_NNP +_NN ionomycin_NN restimulation_NN was_VBD increased_VBN more_JJR than_IN
          6_CD -_: fold_VB when_WRB 5_CD A_DT 6_CD anti-_NN CD_NNP 81_CD mAb_NN had_VBD been_VBN added_VBN to_TO the_DT
          initial_JJ anti-_NN CD_NNP 3_CD culture_NN ._. No_DT significant_JJ change_NN in_IN IL-_NNP 2_CD
          or_CC IFNγ-producing_NNP cells_NNS was_VBD seen_VBN ._. A_DT less_RBR dramatic_JJ
          increase_NN in_IN IL-_NNP 4_CD -_: producing_VBG cells_NNS was_VBD seen_VBN for_IN CD_NNP 45_CD RO_NNP
          -_: cells_NNS (_( Figure_NN 4_CD D_NNP )_) ._. The_DT results_NNS for_IN CD_NNP 8_CD +_NN T_NN cells_NNS mirrored_VBD
          those_DT for_IN CD_NNP 4_CD +_NN T_NN cells_NNS ,_, except_IN that_IN the_DT overall_JJ number_NN of_IN
          IL-_NNP 4_CD -_: producing_VBG CD_NNP 8_CD +_NN T_NN cells_NNS was_VBD lower_JJR (_( data_NNS not_RB
          shown_VBN )_) ._.
          Because_IN the_DT effect_NN of_IN CD_NNP 81_CD on_IN IL-_NNP 4_CD -_: producing_VBG T_NN cells_NNS
          was_VBD most_RBS dramatic_JJ with_IN CD_NNP 45_CD RO_NNP +_NN cells_NNS (_( Figure_NN 4_CD C_NNP )_) ,_, it_PRP was_VBD
          hypothesized_VBN that_IN CD_NNP 81_CD costimulation_NN was_VBD affecting_VBG the_DT
          number_NN of_IN IL-_NNP 4_CD -_: producing_VBG memory_NN T_NN cells_NNS over_IN time_NN ._. To_TO
          determine_VB the_DT effect_NN of_IN CD_NNP 81_CD costimulation_NN over_IN time_NN on_IN
          the_DT absolute_JJ number_NN of_IN IL-_NNP 4_CD -_: or_CC IFNγ-producing_NNP T_NN cells_NNS ,_,
          the_DT experiment_NN of_IN Figure_NN 5_CD was_VBD carried_VBN out_RP ._. CD_NNP 45_CD RO_NNP +_NN T_NN
          cells_NNS were_VBD stimulated_VBN with_IN anti-_NN CD_NNP 3_CD ±_NN anti-_NN CD_NNP 81_CD mAb_NN as_IN in_IN
          Figure_NN 4_CD ,_, but_CC cells_NNS were_VBD restimulated_JJ with_IN PMA_NNP +_NN
          ionomycin_NN after_IN 1_CD ,_, 3_CD ,_, or_CC 7_CD d_SYM of_IN culture_NN ._. The_DT absolute_JJ
          number_NN of_IN IL-_NNP 4_CD -_: and_CC IFNγ-producing_NNP T_NN cells_NNS was_VBD then_RB
          quantified_VBN using_VBG intracellular_NN staining_VBG and_CC TruCount_NNP ™_NN
          beads_NNS ._. As_IN seen_VBN in_IN Figure_NN 5_CD ,_, the_DT number_NN of_IN IL-_NNP 4_CD -_: producing_VBG
          CD_NNP 4_CD T_NN cells_NNS increased_VBD much_RB more_RBR significantly_RB over_IN time_NN
          in_IN cultures_NNS incubated_JJ with_IN anti-_NN CD_NNP 81_CD mAb_NN than_IN in_IN those_DT
          without_IN ._. The_DT number_NN of_IN IFNγ-producing_NNP CD_NNP 4_CD T_NN cells_NNS
          increased_VBN similarly_RB in_IN cultures_NNS incubated_JJ with_IN or_CC without_IN
          anti-_NN CD_NNP 81_CD mAb_NN ._. Thus_RB ,_, CD_NNP 81_CD costimulation_NN appeared_VBD to_TO
          preferentially_RB induce_VB the_DT accumulation_NN of_IN IL-_NNP 4_CD -_: producing_VBG
          T_NN cells_NNS over_IN time_NN ._.
          To_TO further_VB test_NN whether_IN CD_NNP 81_CD costimulation_NN was_VBD
          inducing_VBG preferential_JJ proliferation_NN of_IN IL-_NNP 4_CD -_: producing_VBG
          memory_NN cells_NNS ,_, experiments_NNS with_IN CFSE_NNP labeling_VBG were_VBD carried_VBN
          out_RP ._. As_IN seen_VBN in_IN Figure_NN 6_CD A_DT ,_, the_DT percentage_NN of_IN
          IL-_NNP 4_CD -_: producing_VBG cells_NNS increased_VBN preferentially_RB over_IN time_NN
          in_IN long-term_JJ anti-_NN CD_NNP 3_CD stimulations_NNS that_WDT received_VBD CD_NNP 81_CD
          costimulation_NN ,_, relative_JJ to_TO stimulations_NNS in_IN the_DT absence_NN of_IN
          anti-_NN CD_NNP 81_CD mAb_NN ._. Although_IN CFSE_NNP content_NN was_VBD equal_JJ in_IN all_DT
          cells_NNS on_IN day_NN 0_CD (_( Figure_NN 6_CD B_NNP )_) ,_, the_DT mean_JJ level_NN of_IN CFSE_NNP
          fluorescence_NN of_IN IL-_NNP 4_CD -_: producing_VBG cells_NNS became_VBD lower_JJR over_IN
          time_NN in_IN the_DT presence_NN of_IN CD_NNP 81_CD costimulation_NN versus_CC
          anti-_NN CD_NNP 3_CD stimulation_NN alone_RB (_( Figure_NN 6_CD Band_NNP 6_CD C_NNP )_) ._. This_DT
          indicates_VBZ that_IN IL-_NNP 4_CD -_: producing_VBG cells_NNS had_VBD divided_VBN ,_, on_IN
          average_JJ ,_, more_JJR times_NNS with_IN CD_NNP 81_CD costimulation_NN than_IN without_IN ._.
          The_DT difference_NN was_VBD apparent_JJ after_IN one_CD day_NN of_IN stimulation_NN ,_,
          and_CC did_VBD not_RB increase_VB over_IN time_NN ,_, consistent_JJ with_IN a_DT greater_JJR
          initial_JJ induction_NN of_IN proliferation_NN of_IN IL-_NNP 4_CD -_: producing_VBG
          cells_NNS in_IN the_DT presence_NN of_IN anti-_NN CD_NNP 81_CD ._. There_EX was_VBD no_DT such_JJ
          difference_NN in_IN CFSE_NNP levels_NNS for_IN IFNγ-producing_NNP cells_NNS in_IN the_DT
          presence_NN or_CC absence_NN of_IN anti-_NN CD_NNP 81_CD (_( Figure_NN 6_CD D_NNP )_) ._. However_RB ,_,
          anti-_NN CD_NNP 28_CD costimulation_NN induced_VBN lower_JJR levels_NNS of_IN CFSE_NNP in_IN
          all_DT cells_NNS ,_, including_VBG IFNγ-producing_NNP cells_NNS ,_, after_IN 3_CD days_NNS
          of_IN anti-_NN CD_NNP 3_CD stimulation_NN (_( p_NN <_NN 0_CD ._. 001_CD ,_, data_NNS not_RB shown_VBN )_) ._.
          Thus_RB ,_, CD_NNP 81_CD costimulation_NN appears_VBZ to_TO uniquely_RB induce_VB
          greater_JJR proliferation_NN of_IN IL-_NNP 4_CD -_: producing_VBG cells_NNS relative_JJ to_TO
          other_JJ memory_NN T_NN cell_NN populations_NNS ._.
        
      
      
        Discussion_NNP
        In_IN this_DT study_NN ,_, it_PRP was_VBD shown_VBN that_IN CD_NNP 81_CD ligation_NN on_IN human_JJ
        T_NN cells_NNS costimulates_NNS the_DT induction_NN of_IN CD_NNP 69_CD expression_NN ,_, the_DT
        production_NN of_IN cytokines_NNS ,_, and_CC the_DT proliferation_NN of_IN both_DT CD_NNP 4_CD
        +_NN and_CC CD_NNP 4_CD -_: human_JJ T_NN cells_NNS ._. Greater_NNP effects_NNS were_VBD seen_VBN on_IN CD_NNP 4_CD
        +_NN T_NN cells_NNS compared_VBN to_TO CD_NNP 4_CD -_: T_NN cells_NNS ._. The_DT costimulatory_NN
        effects_NNS were_VBD documented_VBN using_VBG two_CD antigenic_JJ systems_NNS :_: a_DT
        superantigen_NN (_( SEB_NNP )_) ,_, and_CC a_DT conventional_JJ viral_JJ antigen_NN (_( CMV_NNP )_) ._.
        The_DT effects_NNS were_VBD determined_VBN to_TO be_VB a_DT direct_JJ consequence_NN of_IN
        CD_NNP 81_CD ligation_NN on_IN T_NN cells_NNS ,_, as_IN anti-_NN CD_NNP 81_CD mAb_NN pre-treatment_JJ of_IN
        purified_JJ T_NN cells_NNS ,_, but_CC not_RB non-_NN T_NN cells_NNS ,_, induced_VBD the_DT
        costimulatory_NN effects_NNS ._.
        In_IN a_DT previous_JJ study_NN ,_, Van_NNP Compernolle_NNP et_CC al_NN ._. showed_VBD that_IN
        the_DT enhancing_VBG effect_NN of_IN CD_NNP 81_CD on_IN SEB-induced_NNP activation_NN was_VBD
        inhibited_VBD by_IN antibody_NN to_TO LFA-_NNP 1_CD [_NN 17_CD ]_NN ._. The_DT current_JJ results_NNS
        are_VBP consistent_JJ with_IN the_DT model_NN proposed_VBN by_IN VanCompernolle_NNP et_CC
        al_NN ._. ,_, whereby_WRB CD_NNP 81_CD ligation_NN induces_VBZ an_DT increase_NN in_IN LFA-_NNP 1_CD
        avidity_NN for_IN ICAM-_NNP 3_CD on_IN accessory_JJ cells_NNS ,_, resulting_VBG in_IN an_DT
        indirect_JJ activation_NN effect_NN on_IN the_DT T_NN cells_NNS ._. However_RB ,_, in_IN the_DT
        current_JJ study_NN ,_, anti-_NN LFA-_NNP 1_CD was_VBD found_VBN to_TO only_RB partially_RB block_VB
        cytokine_NN production_NN induced_VBN by_IN either_DT SEB_NNP or_CC SEB_NNP +_NN anti-_NN CD_NNP 81_CD
        (_( data_NNS not_RB shown_VBN )_) ._. This_DT suggests_VBZ that_IN CD_NNP 81_CD 's_POS effects_NNS on_IN
        cytokine_NN production_NN may_MD not_RB be_VB uniquely_RB mediated_JJ by_IN LFA-_NNP 1_CD ._.
        In_IN fact_NN ,_, other_JJ investigators_NNS have_VBP shown_VBN that_DT anti-_NN CD_NNP 81_CD mAb_NN
        can_MD directly_RB costimulate_NN purified_JJ murine_NN T_NN cells_NNS [_NN 16_CD ]_NN ,_,
        in_IN a_DT presumably_RB LFA-_NNP 1_CD -_: independent_JJ manner_NN ._.
        CD_NNP 81_CD costimulation_NN increased_VBD in_IN equal_JJ proportion_NN the_DT
        number_NN of_IN T_NN cells_NNS producing_VBG IL-_NNP 2_CD ,_, IFNγ_NNP ,_, and_CC IL-_NNP 4_CD ._. Using_VBG
        CD_NNP 81_CD nullmice_NN ,_, CD_NNP 81_CD was_VBD found_VBN to_TO be_VB required_VBN for_IN effective_JJ
        Th_NNP 2_CD ,_, but_CC not_RB Th_NNP 1_CD ,_, immune_JJ responses_NNS [_NN 20_CD 21_CD 22_CD 23_CD ]_NN ._. But_CC
        CD_NNP 81_CD has_VBZ also_RB been_VBN found_VBN to_TO generally_RB costimulate_NN T_NN cell_NN
        responses_NNS in_IN mouse_NN [_NN 16_CD ]_NN and_CC human_JJ [_NN 17_CD ]_NN ._. Thus_RB ,_, the_DT
        costimulation_NN of_IN T_NN cell_NN cytokine_NN production_NN by_IN CD_NNP 81_CD need_VBP
        not_RB necessarily_RB be_VB biased_VBN towards_IN Th_NNP 2_CD cytokines_NNS ._. The_DT
        current_JJ results_NNS bear_VBP this_DT out_RP ._.
        More_RBR recent_JJ results_NNS have_VBP shown_VBN that_IN CD_NNP 81_CD expression_NN on_IN T_NN
        cells_NNS is_VBZ indeed_RB important_JJ for_IN their_PRP$ induction_NN of_IN IL-_NNP 4_CD
        production_NN [_NN 23_CD ]_NN in_IN a_DT mouse_NN system_NN ._. The_DT current_JJ study_NN
        complements_VBZ these_DT results_NNS by_IN demonstrating_VBG that_IN CD_NNP 81_CD
        directly_RB influences_VBZ the_DT number_NN of_IN IL-_NNP 4_CD -_: producing_VBG T_NN cells_NNS in_IN
        cultures_NNS of_IN stimulated_VBN human_JJ memory_NN T_NN cells_NNS ._. The_DT effect_NN of_IN
        anti-_NN CD_NNP 81_CD mAb_NN was_VBD to_TO increase_VB the_DT absolute_JJ number_NN of_IN
        IL-_NNP 4_CD -_: producing_VBG T_NN cells_NNS over_IN time_NN relative_JJ to_TO cultures_NNS not_RB
        costimulated_JJ with_IN anti-_NN CD_NNP 81_CD mAb_NN ._. Furthermore_RB ,_, the_DT CD_NNP 81_CD
        costimulation_NN appeared_VBD to_TO cause_VB a_DT greater_JJR induction_NN of_IN
        proliferation_NN of_IN IL-_NNP 4_CD -_: producing_VBG cells_NNS ,_, relative_JJ to_TO that_DT
        seen_VBN in_IN the_DT absence_NN of_IN CD_NNP 81_CD mAb_NN ._.
        The_DT effect_NN of_IN CD_NNP 81_CD costimulation_NN on_IN the_DT number_NN of_IN
        IL-_NNP 4_CD -_: producing_VBG T_NN cells_NNS could_MD occur_VB through_IN several_JJ
        different_JJ mechanisms_NNS ._. First_LS ,_, it_PRP is_VBZ possible_JJ that_IN CD_NNP 81_CD
        induces_VBZ recruitment_NN of_IN naïve_NN cells_NNS to_TO the_DT Th_NNP 2_CD pathway_NN ._. This_DT
        did_VBD not_RB appear_VB to_TO be_VB the_DT case_NN ,_, as_IN the_DT effect_NN of_IN CD_NNP 81_CD was_VBD
        most_RBS prominent_JJ on_IN CD_NNP 45_CD RO_NNP +_NN cells_NNS ,_, which_WDT do_VBP not_RB include_VB naïve_NN
        T_NN cells_NNS ._. However_RB ,_, CD_NNP 81_CD signalling_VBG could_MD induce_VB the_DT
        switching_NN of_IN some_DT IFNγ-producing_NNP (_( Th_NNP 1_LS )_) T_NN cells_NNS to_TO
        IL-_NNP 4_CD -_: producing_VBG (_( Th_NNP 2_LS )_) T_NN cells_NNS over_IN time_NN ._. This_DT is_VBZ a_DT difficult_JJ
        mechanism_NN to_TO test_VB ,_, due_JJ to_TO the_DT low_JJ number_NN of_IN IL-_NNP 4_CD -_: producing_VBG
        T_NN cells_NNS in_IN human_JJ PBMC_NNP relative_JJ to_TO IFNγ-producing_NNP T_NN cells_NNS ._.
        Experiments_NNS attempting_VBG to_TO deplete_VB IL-_NNP 4_CD -_: producing_VBG T_NN cells_NNS
        prior_RB to_TO anti-_NN CD_NNP 3_CD stimulation_NN were_VBD attempted_VBN ,_, but_CC could_MD not_RB
        be_VB accurately_RB interpreted_VBN ,_, since_IN depletion_NN of_IN 100_CD %_NN of_IN
        potential_JJ IL-_NNP 4_CD -_: producing_VBG cells_NNS could_MD not_RB be_VB documented_VBN
        (_( data_NNS not_RB shown_VBN )_) ._. It_PRP was_VBD thus_RB impossible_JJ to_TO rule_VB out_RP this_DT
        mechanism_NN as_RB possibly_RB contributing_VBG to_TO the_DT accumulation_NN of_IN
        IL-_NNP 4_CD -_: producing_VBG cells_NNS over_IN time_NN ,_, although_IN it_PRP did_VBD not_RB appear_VB
        to_TO be_VB the_DT major_JJ mechanism_NN (_( see_VB below_IN )_) ._.
        Second_JJ ,_, it_PRP is_VBZ possible_JJ that_IN CD_NNP 81_CD costimulation_NN
        preferentially_RB rescues_VBZ IL-_NNP 4_CD -_: producing_VBG T_NN cells_NNS from_IN
        apoptosis_NNS ,_, and_CC thus_RB they_PRP accumulate_VBP to_TO a_DT greater_JJR degree_NN
        over_IN time_NN ._. This_DT did_VBD not_RB appear_VB to_TO be_VB the_DT case_NN ,_, as_IN
        IL-_NNP 4_CD -_: producing_VBG T_NN cells_NNS were_VBD no_DT more_RBR likely_JJ to_TO be_VB apoptotic_JJ
        than_IN IFNγ-producing_NNP or_CC IL-_NNP 4_CD -_: negative_JJ T_NN cells_NNS in_IN long-term_JJ
        stimulations_NNS (_( data_NNS not_RB shown_VBN )_) ._.
        Finally_RB ,_, it_PRP is_VBZ possible_JJ that_IN CD_NNP 81_CD induces_VBZ preferential_JJ
        proliferation_NN of_IN IL-_NNP 4_CD -_: producing_VBG T_NN cells_NNS relative_JJ to_TO other_JJ T_NN
        cells_NNS ._. This_DT indeed_RB appears_VBZ to_TO be_VB the_DT case_NN ,_, as_IN seen_VBN by_IN
        proliferation_NN experiments_NNS using_VBG CFSE_NNP (_( see_VB Figure_NN 6_CD )_) ._. As_IN
        cells_NNS divide_VBP ,_, this_DT cytosolic_JJ dye_NN is_VBZ diluted_VBN ,_, such_JJ that_IN
        cells_NNS express_VBP lower_JJR levels_NNS of_IN CFSE_NNP with_IN each_DT successive_JJ
        division_NN ._. Indeed_RB ,_, after_IN just_RB one_CD day_NN of_IN stimulation_NN ,_,
        IL-_NNP 4_CD -_: producing_VBG cells_NNS in_IN the_DT presence_NN of_IN CD_NNP 81_CD costimulation_NN
        had_VBD lower_JJR mean_NN levels_NNS of_IN CFSE_NNP than_IN did_VBD IL-_NNP 4_CD -_: producing_VBG cells_NNS
        in_IN the_DT absence_NN of_IN CD_NNP 81_CD costimulation_NN ._. This_DT was_VBD not_RB true_JJ for_IN
        IL-_NNP 4_CD -_: negative_JJ or_CC IFNγ-producing_NNP cells_NNS ._. The_DT relative_JJ amount_NN
        of_IN CFSE_NNP in_IN CD_NNP 81_CD -_: costimulated_JJ cultures_NNS versus_CC
        non-costimulated_JJ cultures_NNS did_VBD not_RB change_VB further_RB over_IN time_NN ._.
        Thus_RB ,_, it_PRP did_VBD not_RB appear_VB that_IN IL-_NNP 4_CD -_: producing_VBG cells_NNS were_VBD
        continually_RB proliferating_VBG faster_RBR in_IN the_DT presence_NN of_IN CD_NNP 81_CD
        costimulation_NN ._. Rather_RB ,_, they_PRP appeared_VBD to_TO be_VB more_RBR readily_RB
        induced_VBN into_IN proliferation_NN ,_, as_IN the_DT maximum_NN difference_NN in_IN
        CFSE_NNP levels_NNS was_VBD already_RB observed_VBN after_IN one_CD day_NN of_IN
        stimulation_NN ._. Thus_RB ,_, the_DT primary_JJ mechanism_NN by_IN which_WDT CD_NNP 81_CD
        costimulation_NN induces_VBZ Th_NNP 2_CD bias_NN in_IN long-term_JJ stimulation_NN
        appears_VBZ to_TO be_VB a_DT greater_JJR induction_NN of_IN proliferation_NN in_IN
        IL-_NNP 4_CD -_: producing_VBG cells_NNS ._. This_DT complements_VBZ the_DT findings_NNS of_IN Deng_NNP
        et_CC al_NN ._. [_NN 23_CD ]_NN ,_, in_IN which_WDT the_DT lack_NN of_IN CD_NNP 81_CD in_IN a_DT murine_NN
        culture_NN system_NN correlated_JJ with_IN decreased_VBD expression_NN of_IN
        signalling_VBG molecules_NNS critical_JJ for_IN activation_NN and_CC IL-_NNP 4_CD
        production_NN ._. This_DT effect_NN of_IN CD_NNP 81_CD is_VBZ not_RB shared_VBN by_IN other_JJ
        classical_JJ costimulatory_NN molecules_NNS ,_, such_JJ as_IN CD_NNP 28_CD ,_, which_WDT has_VBZ
        been_VBN shown_VBN to_TO induce_VB the_DT proliferation_NN of_IN both_DT Th_NNP 1_CD and_CC Th_NNP 2_CD
        cells_NNS (_( data_NNS not_RB shown_VBN ,_, and_CC references_NNS [_NN 26_CD 27_CD 28_CD 29_CD ]_NN
        )_) ._.
        It_PRP should_MD be_VB noted_VBN that_IN the_DT present_JJ study_NN ,_, due_JJ to_TO
        limitations_NNS of_IN working_VBG with_IN human_JJ PBMC_NNP ,_, could_MD not_RB address_VB
        the_DT results_NNS of_IN withdrawing_VBG endogenous_JJ CD_NNP 81_CD signalling_VBG ._.
        Rather_RB ,_, CD_NNP 81_CD co-stimulation_JJ could_MD only_RB be_VB increased_VBN over_IN
        basal_NN levels_NNS by_IN application_NN of_IN an_DT agonistic_JJ mAb_NN ,_, 5_CD A_DT 6_CD ._.
        Because_IN endogenous_JJ CD_NNP 81_CD costimulation_NN could_MD still_RB occur_VB in_IN
        cultures_NNS without_IN 5_CD A_DT 6_CD added_VBD ,_, the_DT differences_NNS due_JJ to_TO addition_NN
        of_IN 5_CD A_DT 6_CD might_MD actually_RB underestimate_NN the_DT full_JJ potential_NN of_IN
        CD_NNP 81_CD 's_POS effect_NN ._. This_DT caveat_NN of_IN the_DT experimental_JJ system_NN also_RB
        implies_VBZ that_IN there_EX could_MD be_VB considerable_JJ donor-to-donor_JJ
        variability_NN in_IN the_DT effect_NN of_IN anti-_NN CD_NNP 81_CD mAb_NN ,_, as_IN different_JJ
        donors_NNS could_MD have_VB different_JJ levels_NNS of_IN endogenous_JJ CD_NNP 81_CD
        costimulatory_NN activity_NN ._. The_DT natural_JJ ligand_NN for_IN CD_NNP 81_CD has_VBZ
        never_RB been_VBN identified_VBN ._.
      
      
        Conclusions_NNP
        In_IN conclusion_NN ,_, CD_NNP 81_CD costimulation_NN appears_VBZ to_TO have_VB
        multiple_JJ effects_NNS on_IN T_NN cells_NNS ,_, including_VBG costimulation_NN of_IN Th_NNP 1_CD
        and_CC Th_NNP 2_CD cytokine_NN production_NN in_IN short-term_JJ assays_NNS ,_, and_CC
        preferential_JJ induction_NN of_IN Th_NNP 2_CD cell_NN proliferation_NN in_IN
        long-term_JJ cultures_NNS of_IN human_JJ memory_NN T_NN cells_NNS ._. These_DT results_NNS
        expand_VBP upon_IN and_CC help_VB to_TO explain_VB the_DT Th_NNP 2_CD -_: biasing_VBG effects_NNS of_IN
        CD_NNP 81_CD in_IN mouse_NN [_NN 21_CD 22_CD 23_CD ]_NN and_CC human_JJ [_NN 19_CD ]_NN systems_NNS ._.
      
      
        Methods_NNP
        
          Cells_NNP and_CC cell_NN separation_NN
          Peripheral_NNP blood_NN from_IN normal_JJ human_JJ donors_NNS was_VBD
          collected_VBN under_IN informed_VBN consent_NN in_IN accordance_NN with_IN an_DT
          institutionally-approved_JJ and_CC physician-supervised_JJ
          protocol_NN ._. Blood_NNP was_VBD collected_VBN in_IN heparinized_JJ Vacutainer_NNP ™_NN
          tubes_NNS or_CC heparinized_JJ CPT_NNP tubes_NNS (_( BD_NNP Vacutainer_NNP ,_, Franklin_NNP
          Lakes_NNP ,_, NJ_NNP )_) ._. CPT_NNP tubes_NNS were_VBD centrifuged_JJ as_IN directed_VBN by_IN the_DT
          manufacturer_NN to_TO obtain_VB peripheral_JJ blood_NN mononuclear_NN cells_NNS
          (_( PBMC_NNP )_) ._. These_DT were_VBD resuspended_JJ for_IN stimulation_NN in_IN the_DT
          autologous_JJ plasma_NN ._. For_IN the_DT experiments_NNS of_IN Figures_NNS 3_CD ,_, 4_CD ,_,
          5_CD ,_, 6_CD ,_, PBMC_NNP were_VBD further_JJ fractionated_JJ using_VBG magnetic_JJ beads_NNS
          (_( Milltenyi_NNP Biotec_NNP ,_, Auburn_NNP ,_, CA_NNP )_) to_TO deplete_VB non-_NN T_NN cells_NNS ,_,
          and_CC /_NN or_CC to_TO select_VB for_IN CD_NNP 45_CD RO_NNP +_NN versus_CC CD_NNP 45_CD RO_NNP -_: cells_NNS ._. Cell_NNP
          separation_NN was_VBD performed_VBN on_IN an_DT AutoMACS_NNP system_NN
          (_( Milltenyi_NNP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ._.
          For_IN Figure_NN 4_CD ,_, separated_JJ cells_NNS were_VBD then_RB aliquoted_JJ and_CC
          treated_VBN (_( or_CC not_RB )_) with_IN 5_CD μg_NN /_NN ml_NN 5_CD A_DT 6_CD anti-_NN CD_NNP 81_CD mAb_NN (_( [_NN 11_CD ]_NN
          ,_, a_DT gift_NN of_IN Shoshana_NNP Levy_NNP ,_, Stanford_NNP University_NNP )_) for_IN one_CD
          hour_NN on_IN ice_NN ._. Cells_NNP were_VBD then_RB washed_VBN twice_RB with_IN medium_NN ,_,
          and_CC resuspended_JJ in_IN 0_CD ._. 5_CD ml_NN medium_NN ._. T_NN cells_NNS (_( treated_VBN or_CC
          not_RB )_) were_VBD recombined_JJ with_IN non-_NN T_NN cells_NNS (_( treated_VBN or_CC not_RB )_)
          for_IN stimulation_NN with_IN SEB_NNP as_IN described_VBN below_IN ._. Medium_NNP
          consisted_VBD of_IN RPMI-_NNP 1640_CD +_NN 10_CD %_NN fetal_JJ bovine_JJ serum_NN and_CC
          antibiotics_NNS ._.
        
        
          Antigens_NNP
          Human_NNP cytomegalovirus_JJ (_( CMV_NNP )_) lysate_NN was_VBD obtained_VBN from_IN
          Advanced_NNP Biotechnologies_NNP (_( Columbia_NNP ,_, MD_NNP )_) ,_, aliquoted_JJ and_CC
          stored_VBD at_IN -_: 80_CD °_NN C_NNP ,_, and_CC used_VBD at_IN the_DT doses_NNS indicated_VBD in_IN the_DT
          figures_NNS ._. Staphlococcal_NNP enterotoxin_NN B_NNP (_( SEB_NNP )_) ,_, a_DT
          superantigen_NN ,_, was_VBD obtained_VBN from_IN Sigma_NNP Chemical_NNP Co_NNP ._. (_( St_NNP ._.
          Louis_NNP ,_, MO_NNP )_) ,_, and_CC used_VBD at_IN the_DT doses_NNS indicated_VBD in_IN the_DT
          figures_NNS ._.
        
        
          Short-term_JJ stimulations_NNS
          0_CD ._. 2_CD -_: 1_CD ml_NN of_IN whole_JJ blood_NN or_CC PBMC_NNP was_VBD stimulated_VBN in_IN 15_CD
          ml_NN conical_JJ polypropylene_NN tubes_NNS (_( Falcon_NNP ,_, BD_NNP Discovery_NNP
          Labware_NNP ,_, Bedford_NNP ,_, MA_NNP )_) or_CC 2_CD ml_NN microtubes_NNS (_( Sorenson_NNP
          BioScience_NNP ,_, Salt_NNP Lake_NNP City_NNP ,_, UT_NNP )_) ._. For_IN experiments_NNS
          examining_VBG cytokine_NN production_NN and_CC CD_NNP 69_CD induction_NN ,_, whole_JJ
          blood_NN or_CC PBMC_NNP were_VBD incubated_JJ with_IN antigen_NN or_CC superantigen_NN
          for_IN 6_CD h_NN at_IN 37_CD °_NN C_NNP ,_, with_IN addition_NN of_IN 10_CD μg_NN /_NN ml_NN Brefeldin_NNP A_DT
          (_( Sigma_NNP )_) at_IN 2_CD h_NN ._. For_IN experiments_NNS examining_VBG proliferation_NN ,_,
          PBMC_NNP were_VBD incubated_JJ with_IN SEB_NNP for_IN 48_CD h_NN at_IN 37_CD °_NN C_NNP ,_, with_IN
          addition_NN of_IN 60_CD μM_NN BrdU_NNP (_( Sigma_NNP )_) and_CC 10_CD μg_NN /_NN ml_NN Brefeldin_NNP A_DT
          for_IN the_DT last_JJ 6_CD h_NN ._. Whole_JJ blood_NN was_VBD incubated_JJ in_IN upright_NN
          tubes_NNS ,_, while_IN PBMC_NNP were_VBD incubated_JJ in_IN tubes_NNS slanted_JJ to_TO 5_CD °_NN
          above_IN horizontal_NN ._. Incubations_NNP were_VBD carried_VBN out_IN in_IN the_DT
          presence_NN or_CC absence_NN of_IN 5_CD μg_NN /_NN ml_NN purified_JJ 5_CD A_DT 6_CD anti-human_JJ
          CD_NNP 81_CD mAb_NN ._.
        
        
          Long-term_JJ stimulations_NNS
          For_IN stimulation_NN with_IN anti-_NN CD_NNP 3_CD mAb_NN ,_, 24_CD -_: well_RB or_CC 6_CD -_: well_RB
          tissue_NN culture_NN plates_NNS (_( Falcon_NNP )_) were_VBD coated_VBN with_IN purified_JJ
          anti-_NN CD_NNP 3_CD mAb_NN (_( clone_NN JE_NNP 6_CD [_NN 30_CD ]_NN )_) ._. A_DT 10_CD μg_NN /_NN ml_NN solution_NN of_IN
          JE_NNP 6_CD in_IN PBS_NNP was_VBD added_VBN to_TO each_DT well_RB and_CC incubated_JJ for_IN 2_CD h_NN
          at_IN 37_CD °_NN C_NNP ._. Wells_NNP were_VBD then_RB washed_VBN several_JJ times_NNS with_IN PBS_NNP
          prior_RB to_TO addition_NN of_IN cells_NNS ._. PBMC_NNP ,_, or_CC fractions_NNS of_IN PBMC_NNP
          isolated_VBN by_IN magnetic_JJ bead_NN separation_NN ,_, were_VBD resuspended_JJ in_IN
          RPMI_NNP medium_NN +_NN 10_CD %_NN fetal_JJ bovine_JJ serum_NN (_( Sigma_NNP )_) ,_,
          supplemented_JJ with_IN L-_NNP glutamine_NN and_CC antibiotics_NNS ,_, and_CC plated_JJ
          at_IN approximately_RB 10_CD 6_CD cells_NNS per_IN ml_NN ._. The_DT cells_NNS were_VBD
          stimulated_VBN either_CC with_IN plate-bound_JJ anti-_NN CD_NNP 3_CD mAb_NN (_( coated_JJ
          as_IN described_VBN above_IN )_) or_CC soluble_JJ SEB_NNP superantigen_NN (_( Sigma_NNP ,_,
          at_IN 1_CD μg_NN /_NN ml_NN final_JJ concentration_NN )_) ,_, in_IN the_DT presence_NN or_CC
          absence_NN of_IN 5_CD -_: 10_CD μg_NN /_NN ml_NN 5_CD A_DT 6_CD anti-_NN CD_NNP 81_CD mAb_NN (_( added_VBD only_RB at_IN
          the_DT initiation_NN of_IN the_DT culture_NN )_) ._. After_IN 1_CD -_: 7_CD days_NNS ,_, cells_NNS
          were_VBD stimulated_VBN for_IN 4_CD h_NN with_IN 10_CD ng_NN /_NN ml_NN PMA_NNP +_NN 1_CD μg_NN /_NN ml_NN
          ionomycin_NN (_( both_DT from_IN Sigma_NNP )_) ,_, in_IN the_DT presence_NN of_IN 10_CD μg_NN /_NN ml_NN
          Brefeldin_NNP A_DT ._.
        
        
          Cell_NNP preparation_NN and_CC staining_VBG
          Cells_NNP were_VBD prepared_VBN for_IN cytokine_NN flow_NN cytometry_NN as_IN
          described_VBN previously_RB [_NN 31_CD 32_CD 33_CD ]_NN ._. Briefly_NNP ,_, cells_NNS were_VBD
          incubated_JJ 15_CD min_NN with_IN 2_CD mM_NN EDTA_NNP to_TO remove_VB adherent_NN cells_NNS ,_,
          then_RB treated_VBN with_IN 10_CD volumes_NNS of_IN FACS_NNP Lysing_NNP Solution_NN (_( BD_NNP
          Biosciences_NNP ,_, Immunocytometry_NNP Systems_NNPS ,_, San_NNP Jose_NNP ,_, CA_NNP )_) for_IN
          10_CD min_NN at_IN room_NN temperature_NN ._. Cells_NNP were_VBD washed_VBN ,_, aliquoted_JJ
          into_IN 12_CD ×_NN 75_CD mm_NN polystyrene_NN tubes_NNS (_( Falcon_NNP )_) ,_, and_CC treated_VBD
          with_IN 0_CD ._. 5_CD ml_NN FACS_NNP Permeabilizing_NNP Solution_NN 2_CD (_( BD_NNP
          Immunocytometry_NNP Systems_NNPS )_) for_IN 10_CD min_NN at_IN room_NN temperature_NN ._.
          After_IN washing_VBG once_RB more_JJR ,_, cells_NNS were_VBD stained_JJ (_( 30_CD -_: 60_CD min_NN at_IN
          room_NN temperature_NN )_) for_IN flow_NN cytometry_NN ,_, typically_RB with_IN
          anti-cytokine_JJ FITC_NNP /_NN CD_NNP 69_CD PE_NNP /_NN CD_NNP 4_CD PerCP-Cy_NNP 5_CD ._. 5_LS /_NN CD_NNP 3_CD APC_NNP ._. For_IN
          proliferation_NN experiments_NNS ,_, cells_NNS were_VBD stained_JJ with_IN
          anti-_NN BrdU_NNP FITC_NNP /_NN anti-cytokine_JJ PE_NNP /_NN CD_NNP 4_CD PerCP_NNP (_( all_DT antibodies_NNS
          from_IN BD_NNP Immunocytometry_NNP Systems_NNPS )_) ._. After_IN an_DT additional_JJ
          wash_NN ,_, cells_NNS were_VBD fixed_VBN with_IN 1_CD %_NN paraformaldehyde_NN for_IN flow_NN
          cytometry_NN analysis_NN ._.
        
        
          Flow_NNP cytometry_NN
          Samples_NNP were_VBD collected_VBN on_IN a_DT FACSCalibur_NNP flow_NN cytometer_NN
          using_VBG CellQuest_NNP software_NN (_( BD_NNP Immunocytometry_NNP Systems_NNPS )_) ._. In_IN
          general_JJ ,_, 20_CD ,_, 000_CD -_: 100_CD ,_, 000_CD CD_NNP 3_CD -_: gated_JJ (_( or_CC ,_, in_IN some_DT
          experiments_NNS ,_, CD_NNP 4_CD -_: gated_JJ )_) lymphcytes_NNS were_VBD acquired_VBN ,_, using_VBG a_DT
          logical_JJ gate_NN on_IN forward_RB versus_CC side_NN scatter_NN and_CC CD_NNP 3_CD (_( or_CC
          CD_NNP 4_LS )_) versus_CC side_NN scatter_NN ._. For_IN experiments_NNS examining_VBG
          cytokine_NN production_NN and_CC CD_NNP 69_CD induction_NN ,_, a_DT "_'' response_NN
          region_NN "_'' was_VBD defined_VBN for_IN CD_NNP 69_CD +_NN cytokine_NN +_NN cells_NNS using_VBG a_DT
          positive_JJ control_NN such_JJ as_IN SEB_NNP stimulation_NN ,_, on_IN a_DT CD_NNP 4_CD -_: gated_JJ
          dot_VBP plot_NN ._. Background_NNP responses_NNS in_IN the_DT presence_NN of_IN 5_CD A_DT 6_CD
          anti-_NN CD_NNP 81_CD antibody_NN alone_RB were_VBD less_JJR than_IN 0_CD ._. 05_CD %_NN in_IN all_DT
          experiments_NNS shown_VBN ._.
        
        
          Absolute_JJ cell_NN counts_NNS
          Absolute_JJ numbers_NNS of_IN CD_NNP 4_CD +_NN T_NN cells_NNS producing_VBG IL-_NNP 4_CD or_CC
          IFNγ_NNP were_VBD calculated_VBN by_IN spiking_VBG samples_NNS ,_, processed_VBN and_CC
          stained_JJ as_IN above_IN ,_, with_IN 10_CD μl_NN of_IN TruCount_NNP ™_NN High_NNP control_NN
          beads_NNS (_( BD_NNP Immunocytometry_NNP Systems_NNPS )_) ._. Samples_NNP were_VBD then_RB
          acquired_VBN with_IN a_DT threshold_NN on_IN FL_NNP 4_CD (_( CD_NNP 3_LS )_) ,_, rather_RB than_IN
          forward_RB scatter_NN ,_, and_CC the_DT number_NN of_IN beads_NNS per_IN sample_NN were_VBD
          calculated_VBN by_IN gating_VBG on_IN the_DT bead_NN population_NN in_IN a_DT forward_RB
          versus_CC side_NN scatter_NN dot_VBP plot_NN ._. The_DT number_NN of_IN
          cytokine-producing_JJ cells_NNS per_IN ml_NN were_VBD then_RB calculated_VBN as_IN :_:
          [_NN (_( number_NN of_IN gated_JJ cells_NNS )_) /_NN (_( number_NN of_IN gated_JJ beads_NNS )_) ]_NN ×_NN
          [_NN number_NN of_IN beads_NNS per_IN sample_NN ]_NN ._.
        
        
          CFSE_NNP labeling_VBG
          PBMC_NNP magnetically_RB enriched_JJ for_IN CD_NNP 45_CD RO_NNP +_NN cells_NNS were_VBD
          labeled_VBN with_IN 5_CD (_( 6_CD )_) -_: carboxyfluorescein_NN diacetate_NN ,_,
          succinimidyl_NN ester_NN (_( CFSE_NNP ,_, Sigma_NNP )_) as_IN follows_VBZ ._. A_DT 0_CD ._. 5_CD mM_NN
          stock_NN solution_NN of_IN CFSE_NNP in_IN DMSO_NNP was_VBD aliquoted_JJ and_CC stored_VBD
          at_IN -_: 20_CD °_NN C_NNP ._. Just_RB prior_RB to_TO use_VB ,_, an_DT aliquot_NN was_VBD thawed_JJ and_CC 2_CD
          μl_NN of_IN stock_NN solution_NN were_VBD diluted_VBN into_IN 10_CD ml_NN of_IN PBS_NNP ._.
          CD_NNP 45_CD RO_NNP +_NN cells_NNS were_VBD washed_VBN once_RB in_IN PBS_NNP and_CC resuspended_JJ in_IN
          1_CD ml_NN of_IN the_DT CFSE_NNP /_NN PBS_NNP solution_NN ._. After_IN incubating_VBG 2_CD min_NN at_IN
          room_NN temperature_NN ,_, the_DT cells_NNS were_VBD washed_VBN once_RB with_IN 10_CD ml_NN
          of_IN RPMI_NNP medium_NN +_NN 10_CD %_NN fetal_JJ bovine_JJ serum_NN (_( supplemented_JJ
          with_IN L-_NNP glutamine_NN and_CC antibiotics_NNS )_) ._. They_PRP were_VBD then_RB plated_JJ
          in_IN wells_NNS of_IN a_DT 24_CD -_: well_RB plate_NN as_RB under_IN "_'' Long_NNP term_NN
          stimulations_NNS "_'' above_IN ._.
        
      
    
  
